Featured Posts

Wall Street Journal
A Thumb on the Scale for Wegovy
The Biden administration announced one more bit of executive overreach on its way out the door. On Nov. 26, the Centers for Medicare and Medicaid…

Study
Evaluating Telehealth
Executive Summary Why Did We Write This Report Telehealth—the use of remote audio and/or video technologies to provide health care services—has been promoted as…

News Release
Report: Telehealth flexibility deadline looms, but Congress needs better information to decide
Congress is poised to consider proposals that permanently or temporarily extend flexibilities for telehealth services enacted during the COVID-19 pandemic that are set to expire…
Search Posts
The Washington Journal
Video: Dr. Joel Zinberg Joins the Washington Journal to Discuss COVID Lockdowns
Dr. Joel Zinberg joins the Washington Journal to discuss the efficacy of COVID lockdowns and government restrictions as they relate to public health and take…
National Review
Fauci Changes His Public Tune on Covid Vaccines
Dr. Anthony Fauci has finally acknowledged that there had always been good scientific reasons to believe that vaccines against the respiratory…
New York Post
The numbers prove Cuomo’s lockdowns hurt NYers on EVERY metric — while Florida flourished
What a difference a few years make. In 2020, the mainstream media lauded Gov. Andrew Cuomo for his strong but compassionate COVID-19 leadership. He won a…
Fox News
DeSantis’s Florida beats Newsom’s California, again. Here’s the comparison
The COVID-19 pandemic elicited unprecedented government interventions into American life. Yet, the stringency and duration of government measures varied considerably across the U.S. …
Regulatory Transparency Project
AUDIO: Explainer Episode 48 – The FDA & the Practice of Medicine: Possible Regulation of Off-Label Prescriptions
Senior Fellow Joel Zinberg joins the Regulatory Transparency Project to discuss possibly regulation of off-label prescriptions: On December 29, 2022, President Biden signed the Consolidated Appropriations…
Citation
FDA’s Medical Interference, Time for ESG Antitrust Action and other commentary
Libertarian: FDA’s Medical Interference The Wall Street Journal quoted Joel Zinberg on FDA banning practices: “Secreted within the 2023 omnibus appropriations…